Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection
Abstract Salmonella Typhimurium causes a self-limiting gastroenteritis that may lead to systemic disease. Bacteria invade the small intestine, crossing the intestinal epithelium from where they are transported to the mesenteric lymph nodes (MLNs) within migrating immune cells. MLNs are an important...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a24c8a8c4bd40bd88a9c66a0de21e92 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3a24c8a8c4bd40bd88a9c66a0de21e92 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3a24c8a8c4bd40bd88a9c66a0de21e922021-12-02T15:06:17ZMass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection10.1038/s41598-017-03100-52045-2322https://doaj.org/article/3a24c8a8c4bd40bd88a9c66a0de21e922017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03100-5https://doaj.org/toc/2045-2322Abstract Salmonella Typhimurium causes a self-limiting gastroenteritis that may lead to systemic disease. Bacteria invade the small intestine, crossing the intestinal epithelium from where they are transported to the mesenteric lymph nodes (MLNs) within migrating immune cells. MLNs are an important site at which the innate and adaptive immune responses converge but their architecture and function is severely disrupted during S. Typhimurium infection. To further understand host-pathogen interactions at this site, we used mass spectrometry imaging (MSI) to analyse MLN tissue from a murine model of S. Typhimurium infection. A molecule, identified as palmitoylcarnitine (PalC), was of particular interest due to its high abundance at loci of S. Typhimurium infection and MLN disruption. High levels of PalC localised to sites within the MLNs where B and T cells were absent and where the perimeter of CD169+ sub capsular sinus macrophages was disrupted. MLN cells cultured ex vivo and treated with PalC had reduced CD4+CD25+ T cells and an increased number of B220+CD19+ B cells. The reduction in CD4+CD25+ T cells was likely due to apoptosis driven by increased caspase-3/7 activity. These data indicate that PalC significantly alters the host response in the MLNs, acting as a decisive factor in infection outcome.Heather E. HulmeLynsey M. MeikleHannah WesselNicole StrittmatterJohn SwalesCarolyn ThomsonAnna NilssonRobert J. B. NibbsSimon MillingPer E. AndrenC. Logan MackayAlex DexterJosephine BunchRichard J. A. GoodwinRichard BurchmoreDaniel M. WallNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Heather E. Hulme Lynsey M. Meikle Hannah Wessel Nicole Strittmatter John Swales Carolyn Thomson Anna Nilsson Robert J. B. Nibbs Simon Milling Per E. Andren C. Logan Mackay Alex Dexter Josephine Bunch Richard J. A. Goodwin Richard Burchmore Daniel M. Wall Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection |
description |
Abstract Salmonella Typhimurium causes a self-limiting gastroenteritis that may lead to systemic disease. Bacteria invade the small intestine, crossing the intestinal epithelium from where they are transported to the mesenteric lymph nodes (MLNs) within migrating immune cells. MLNs are an important site at which the innate and adaptive immune responses converge but their architecture and function is severely disrupted during S. Typhimurium infection. To further understand host-pathogen interactions at this site, we used mass spectrometry imaging (MSI) to analyse MLN tissue from a murine model of S. Typhimurium infection. A molecule, identified as palmitoylcarnitine (PalC), was of particular interest due to its high abundance at loci of S. Typhimurium infection and MLN disruption. High levels of PalC localised to sites within the MLNs where B and T cells were absent and where the perimeter of CD169+ sub capsular sinus macrophages was disrupted. MLN cells cultured ex vivo and treated with PalC had reduced CD4+CD25+ T cells and an increased number of B220+CD19+ B cells. The reduction in CD4+CD25+ T cells was likely due to apoptosis driven by increased caspase-3/7 activity. These data indicate that PalC significantly alters the host response in the MLNs, acting as a decisive factor in infection outcome. |
format |
article |
author |
Heather E. Hulme Lynsey M. Meikle Hannah Wessel Nicole Strittmatter John Swales Carolyn Thomson Anna Nilsson Robert J. B. Nibbs Simon Milling Per E. Andren C. Logan Mackay Alex Dexter Josephine Bunch Richard J. A. Goodwin Richard Burchmore Daniel M. Wall |
author_facet |
Heather E. Hulme Lynsey M. Meikle Hannah Wessel Nicole Strittmatter John Swales Carolyn Thomson Anna Nilsson Robert J. B. Nibbs Simon Milling Per E. Andren C. Logan Mackay Alex Dexter Josephine Bunch Richard J. A. Goodwin Richard Burchmore Daniel M. Wall |
author_sort |
Heather E. Hulme |
title |
Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection |
title_short |
Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection |
title_full |
Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection |
title_fullStr |
Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection |
title_full_unstemmed |
Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection |
title_sort |
mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during salmonella typhimurium infection |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/3a24c8a8c4bd40bd88a9c66a0de21e92 |
work_keys_str_mv |
AT heatherehulme massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT lynseymmeikle massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT hannahwessel massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT nicolestrittmatter massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT johnswales massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT carolynthomson massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT annanilsson massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT robertjbnibbs massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT simonmilling massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT pereandren massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT cloganmackay massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT alexdexter massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT josephinebunch massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT richardjagoodwin massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT richardburchmore massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection AT danielmwall massspectrometryimagingidentifiespalmitoylcarnitineasanimmunologicalmediatorduringsalmonellatyphimuriuminfection |
_version_ |
1718388504673648640 |